Table of Content

"1    INTRODUCTION    25
1.1    OBJECTIVES OF THE STUDY    25
1.2    MARKET DEFINITION    25
1.2.1    INCLUSIONS & EXCLUSIONS OF THE STUDY    26
1.3    MARKETS SCOPE    26
1.3.1    MARKETS COVERED    26
FIGURE 1    ECMO MARKET SEGMENTATION    26
1.3.2    YEARS CONSIDERED FOR THE STUDY    27
1.4    CURRENCY USED FOR THE STUDY    27
1.5    KEY MARKET STAKEHOLDERS    27
1.6    SUMMARY OF CHANGES    28
2    RESEARCH METHODOLOGY    29
2.1    RESEARCH DATA    29
FIGURE 2    RESEARCH DESIGN    29
2.1.1    SECONDARY DATA SOURCES    30
2.1.1.1    Indicative list of secondary sources    31
2.1.2    PRIMARY DATA    32
FIGURE 3    BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION AND REGION    33
2.2    MARKET SIZE ESTIMATION METHODOLOGY    33
FIGURE 4    SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS    34
2.3    MARKET DATA VALIDATION AND TRIANGULATION    35
FIGURE 5    DATA TRIANGULATION METHODOLOGY    35
2.4    KEY RESEARCH ASSUMPTIONS    36
2.5    LIMITATIONS    36
2.5.1    METHODOLOGY-RELATED LIMITATIONS    36
2.6    RISK ASSESSMENT    37
TABLE 1    RISK ASSESSMENT: ECMO MARKET    37
2.7    GROWTH RATE ASSUMPTIONS    37
2.8    COVID-19 HEALTH ASSESSMENT    37
2.9    COVID-19 ECONOMIC ASSESSMENT    37
2.10    ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO    38
FIGURE 6    CRITERIA IMPACTING THE GLOBAL ECONOMY    38
FIGURE 7    RECOVERY SCENARIO OF THE GLOBAL ECONOMY (2021–2022)    39

3    EXECUTIVE SUMMARY    40
FIGURE 8    ECMO MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)    40
FIGURE 9    ECMO MARKET SHARE, BY MODALITY, 2021 VS. 2026    40
FIGURE 10    ECMO MARKET, BY COMPONENT, 2021 VS. 2026 (USD MILLION)    41
FIGURE 11    GEOGRAPHICAL SNAPSHOT OF THE ECMO MARKET    42
4    PREMIUM INSIGHTS    43
4.1    ECMO MARKET OVERVIEW    43
FIGURE 12    RISING PREVALENCE OF TARGET DISEASES TO DRIVE MARKET GROWTH    43
4.2    ECMO MARKET SHARE, BY REGION AND PATIENT TYPE (2020)    44
FIGURE 13    NORTH AMERICA DOMINATED THE ECMO MARKET IN 2020    44
4.3    ECMO MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)    44
FIGURE 14    ECMO MACHINES SEGMENT WILL CONTINUE TO DOMINATE
THE ECMO MARKET DURING THE FORECAST PERIOD    44
4.4    ECMO MARKET: GEOGRAPHIC SNAPSHOT    45
FIGURE 15    EMERGING MARKETS ARE ESTIMATED TO REGISTER HIGHER GROWTH RATES THAN DEVELOPED MARKETS    45
5    MARKET OVERVIEW    46
5.1    INTRODUCTION    46
5.2    MARKET DYNAMICS    46
FIGURE 16    ECMO MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    46
5.2.1    DRIVERS    47
5.2.1.1    Increasing prevalence of cardiovascular and respiratory diseases    47
TABLE 2    NUMBER OF DEATHS FROM CARDIOVASCULAR AND RESPIRATORY DISEASES ACROSS THE GLOBE, 1990 VS. 2019    47
5.2.1.2    Growing adoption of ECMO in lung transplantation procedures    47
5.2.1.3    Growth in the number of ECMO centers    48
TABLE 3    GLOBAL INCREASE IN THE NUMBER OF ECMO CENTERS    48
5.2.1.4    Technological advancements in ECMO machines    48
5.2.2    RESTRAINTS    49
5.2.2.1    Complications associated with ECMO    49
5.2.2.2    High cost of ECMO procedures    49
TABLE 4    AVERAGE COST OF ECMO IN VARIOUS COUNTRIES    49
5.2.3    OPPORTUNITIES    50
5.2.3.1    Increasing survival rates with ECMO    50
5.2.4    CHALLENGES    50
5.2.4.1    Shortage of skilled professionals    50
5.2.4.2    Eligibility issues for ECMO    50
5.2.4.3    Issues related to selecting the right equipment    50
5.2.4.4    Risks related to the transport of ECMO patients    51
5.2.4.5    Issues related to treatment decision-making    51

5.3    REGULATORY LANDSCAPE    51
TABLE 5    INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING
THE ECMO MARKET    51
5.3.1    NORTH AMERICA    52
5.3.1.1    US    52
TABLE 6    CLASSIFICATION OF MEDICAL DEVICES BY US FDA    52
5.3.1.2    Canada    53
5.3.2    EUROPE    53
5.3.3    ASIA PACIFIC    53
5.3.3.1    India    53
5.3.3.2    Japan    53
TABLE 7    CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY IN JAPAN    54
5.3.3.3    China    54
TABLE 8    NMPA MEDICAL DEVICE CLASSIFICATION    55
5.4    COVID-19 IMPACT ON THE ECMO MARKET    55
5.4.1    REIMBURSEMENT SCENARIO    55
5.5    PATENT ANALYSIS    56
5.5.1    PATENTS GRANTED FOR ECMO MACHINES    56
TABLE 9    PATENTS GRANTED FROM 2016 TO 2021    57
5.5.2    PUBLICATION TRENDS FOR PATENTS ON ECMO MACHINES    57
TABLE 10    FILED PATENTS, 2000–2021    57
TABLE 11    GRANTED PATENTS, 2010–2021    58
TABLE 12    PUBLISHED PATENTS, 2016–2021    58
5.6    VALUE CHAIN ANALYSIS    58
FIGURE 17    VALUE CHAIN OF THE ECMO MARKET    59
5.7    PRICING TREND ANALYSIS    59
TABLE 13    AVERAGE PRICE OF ECMO, BY COUNTRY, 2020 (USD)    59
5.8    PORTER’S FIVE FORCES ANALYSIS    60
TABLE 14    ECMO MARKET: PORTER’S FIVE FORCES ANALYSIS    60
5.8.1    THREAT OF NEW ENTRANTS    60
FIGURE 18    THREAT OF NEW ENTRANTS    60
5.8.2    THREAT OF SUBSTITUTES    61
FIGURE 19    THREAT OF SUBSTITUTES    61
5.8.3    BARGAINING POWER OF SUPPLIERS    61
FIGURE 20    BARGAINING POWER OF SUPPLIERS    62
5.8.4    BARGAINING POWER OF BUYERS    62
FIGURE 21    BARGAINING POWER OF BUYERS    62
5.8.5    INTENSITY OF COMPETITIVE RIVALRY    63
FIGURE 22    INTENSITY OF COMPETITIVE RIVALRY    63
5.9    ECOSYSTEM LANDSCAPE    63
FIGURE 23    ECMO MARKET: ECOSYSTEM LANDSCAPE    64

6    EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY PRODUCT    65
6.1    INTRODUCTION    66
TABLE 15    ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)    66
6.2    ECMO MACHINES    66
6.2.1    STATIC ECMO MACHINES SEGMENT TO DOMINATE
THE ECMO MACHINES MARKET    66
TABLE 16    ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)    66
TABLE 17    ECMO MACHINES MARKET, BY REGION, 2018–2026 (USD MILLION)    67
TABLE 18    ECMO MACHINES MARKET, BY COMPONENT, 2018–2026 (USD MILLION)    67
TABLE 19    ECMO MACHINES MARKET, BY MODALITY, 2018–2026 (USD MILLION)    67
TABLE 20    ECMO MACHINES MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)    68
TABLE 21    ECMO MACHINES MARKET, BY APPLICATION, 2018–2026 (USD MILLION)    68
6.2.2    PORTABLE ECMO MACHINES    68
TABLE 22    PORTABLE ECMO MACHINES MARKET, BY REGION,
2018–2026 (USD MILLION)    68
TABLE 23    PORTABLE ECMO MACHINES MARKET, BY COMPONENT,
2018–2026 (USD MILLION)    69
TABLE 24    PORTABLE ECMO MACHINES MARKET, BY MODALITY,
2018–2026 (USD MILLION)    69
TABLE 25    PORTABLE ECMO MACHINES MARKET, BY PATIENT TYPE,
2018–2026 (USD MILLION)    69
TABLE 26    PORTABLE ECMO MACHINES MARKET, BY APPLICATION,
2018–2026 (USD MILLION)    70
6.2.3    STATIC ECMO MACHINES    70
TABLE 27    STATIC ECMO MACHINES MARKET, BY REGION, 2018–2026 (USD MILLION)    70
TABLE 28    STATIC ECMO MACHINES MARKET, BY COMPONENT,
2018–2026 (USD MILLION)    70
TABLE 29    STATIC ECMO MACHINES MARKET, BY MODALITY,
2018–2026 (USD MILLION)    71
TABLE 30    STATIC ECMO MACHINES MARKET, BY PATIENT TYPE,
2018–2026 (USD MILLION)    71
TABLE 31    STATIC ECMO MACHINES MARKET, BY APPLICATION,
2018–2026 (USD MILLION)    71
6.3    SOFTWARE    72
6.3.1    SOFTWARE SEGMENT TO GROW AT A STEADY CAGR DURING
THE FORECAST PERIOD    72
TABLE 32    ECMO SOFTWARE MARKET, BY REGION, 2018–2026 (USD MILLION)    72
TABLE 33    ECMO SOFTWARE MARKET, BY MODALITY, 2018–2026 (USD MILLION)    72
TABLE 34    ECMO SOFTWARE MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)    72
TABLE 35    ECMO SOFTWARE MARKET, BY APPLICATION, 2018–2026 (USD MILLION)    73

7    EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY COMPONENT    74
7.1    INTRODUCTION    75
TABLE 36    ECMO MARKET, BY COMPONENT, 2018–2026 (USD MILLION)    75
7.2    PUMPS    75
7.2.1    CENTRIFUGAL BLOOD PUMPS HAVE BECOME THE PUMP OF CHOICE FOR ADULT EXTRACORPOREAL LIFE SUPPORT    75
TABLE 37    ECMO MARKET FOR PUMPS, BY REGION, 2018–2026 (USD MILLION)    75
7.3    OXYGENATORS    76
7.3.1    PMP OXYGENATORS HAVE SIGNIFICANTLY LESS PRIMING VOLUME    76
TABLE 38    ECMO MARKET FOR OXYGENATORS, BY REGION, 2018–2026 (USD MILLION)    76
7.4    CONTROLLERS    76
7.4.1    CONTROLLERS ALLOW OPERATORS OF ECMO CIRCUITS TO ADJUST THE SETTINGS AS NEEDED    76
TABLE 39    ECMO MARKET FOR CONTROLLERS, BY REGION, 2018–2026 (USD MILLION)    77
7.5    CANNULAS    77
7.5.1    THE CHOICE OF CANNULAS IS IMPORTANT IN ECMO PROCEDURES    77
TABLE 40    ECMO MARKET FOR CANNULAS, BY REGION, 2018–2026 (USD MILLION)    77
7.6    ACCESSORIES    78
TABLE 41    ECMO MARKET FOR ACCESSORIES, BY REGION, 2018–2026 (USD MILLION)    78
8    EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY MODALITY    79
8.1    INTRODUCTION    80
TABLE 42    ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION)    80
8.2    VENOARTERIAL ECMO    80
8.2.1    INCREASING INCIDENCE OF HEART-LUNG FAILURE TO DRIVE
THE GROWTH OF THIS MARKET SEGMENT    80
TABLE 43    VENOARTERIAL ECMO MARKET, BY REGION, 2018–2026 (USD MILLION)    81
8.3    VENOVENOUS ECMO    81
8.3.1    VENOVENOUS ECMO IS USED WHEN ADEQUATE
 HEART FUNCTION IS AVAILABLE    81
TABLE 44    VENOVENOUS ECMO MARKET, BY REGION, 2018–2026 (USD MILLION)    81
8.4    ARTERIOVENOUS ECMO    82
8.4.1    ARTERIOVENOUS ECMO MACHINES ARE SMALLER AND MORE PORTABLE    82
TABLE 45    ARTERIOVENOUS ECMO MARKET, BY REGION, 2018–2026 (USD MILLION)    82
9    EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY PATIENT TYPE    83
9.1    INTRODUCTION    84
TABLE 46    COMMON INDICATIONS FOR ECMO IN NEONATES, PEDIATRIC
PATIENTS, AND ADULTS    84
TABLE 47    ECMO MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)    84
9.2    NEONATES    85
9.2.1    A LARGE NUMBER OF NEONATES ARE CARED FOR WITH ECMO WORLDWIDE    85
TABLE 48    ECMO MARKET FOR NEONATES, BY REGION, 2018–2026 (USD MILLION)    85
9.3    PEDIATRIC PATIENTS    86
9.3.1    PEDIATRIC PATIENTS FORM A LARGE PATIENT GROUP FOR ECMO PROCEDURES    86
TABLE 49    ECMO MARKET FOR PEDIATRIC PATIENTS, BY REGION,
2018–2026 (USD MILLION)    86
9.4    ADULTS    86
9.4.1    TECHNOLOGICAL ADVANCEMENTS ARE DRIVING THE USE
OF ECMO IN ADULT PATIENTS    86
TABLE 50    ECMO MARKET FOR ADULTS, BY REGION, 2018–2026 (USD MILLION)    87
10    EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY APPLICATION    88
10.1    INTRODUCTION    89
TABLE 51    ECMO MARKET, BY APPLICATION, 2018–2026 (USD MILLION)    89
10.2    RESPIRATORY APPLICATIONS    89
TABLE 52    ECMO MARKET FOR RESPIRATORY APPLICATIONS, BY REGION,
2018–2026 (USD MILLION)    89
10.2.1    RESPIRATORY APPLICATIONS FOR NEONATES    90
TABLE 53    NUMBER OF NEONATES RECEIVING ECMO SUPPORT FOR RESPIRATORY APPLICATIONS    90
10.2.2    RESPIRATORY APPLICATIONS FOR PEDIATRIC PATIENTS    90
TABLE 54    NUMBER OF PEDIATRIC PATIENTS RECEIVING ECMO SUPPORT FOR RESPIRATORY APPLICATIONS    90
10.2.3    RESPIRATORY APPLICATIONS FOR ADULTS    90
TABLE 55    NUMBER OF ADULTS RECEIVING ECMO SUPPORT
FOR RESPIRATORY APPLICATIONS    90
10.3    CARDIAC APPLICATIONS    91
TABLE 56    ECMO MARKET FOR CARDIAC APPLICATIONS, BY REGION,
2018–2026 (USD MILLION)    91
10.3.1    CARDIAC APPLICATIONS FOR ADULTS    91
10.3.2    CARDIAC APPLICATIONS FOR PEDIATRIC PATIENTS    91
10.3.3    CARDIAC APPLICATIONS FOR NEONATES    91
10.4    EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR)    92
TABLE 57    ECMO MARKET FOR ECPR APPLICATIONS, BY REGION,
2018–2026 (USD MILLION)    92
10.4.1    ECPR APPLICATIONS FOR ADULTS    92
10.4.2    ECPR APPLICATIONS FOR PEDIATRIC PATIENTS    92
10.4.3    ECPR APPLICATIONS FOR NEONATES    93
11    EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY REGION    94
11.1    INTRODUCTION    95
TABLE 58    ECMO MARKET, BY REGION, 2018–2026 (USD MILLION)    95
11.2    NORTH AMERICA    95
FIGURE 24    NORTH AMERICA: ECMO MARKET SNAPSHOT    96
TABLE 59    NORTH AMERICA: ECMO MARKET, BY COUNTRY, 2018–2026 (USD MILLION)    96
TABLE 60    NORTH AMERICA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)    97
TABLE 61    NORTH AMERICA: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION)    97
TABLE 62    NORTH AMERICA: ECMO MARKET, BY COMPONENT,
2018–2026 (USD MILLION)    97
TABLE 63    NORTH AMERICA: ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION)    98
TABLE 64    NORTH AMERICA: ECMO MARKET, BY PATIENT TYPE,
2018–2026 (USD MILLION)    98
TABLE 65    NORTH AMERICA: ECMO MARKET, BY APPLICATION,
2018–2026 (USD MILLION)    98
11.2.1    US    99
11.2.1.1    US accounted for the largest share of the North American market    99
TABLE 66    US: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)    99
TABLE 67    US: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)    99
11.2.2    CANADA    100
11.2.2.1    Implementation of the ABF model in Canadian hospitals to drive market growth    100
TABLE 68    CANADA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)    100
TABLE 69    CANADA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)    100
11.3    EUROPE    101
TABLE 70    EUROPE: ECMO MARKET, BY COUNTRY, 2018–2026 (USD MILLION)    101
TABLE 71    EUROPE: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)    101
TABLE 72    EUROPE: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)    101
TABLE 73    EUROPE: ECMO MARKET, BY COMPONENT, 2018–2026 (USD MILLION)    102
TABLE 74    EUROPE: ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION)    102
TABLE 75    EUROPE: ECMO MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)    102
TABLE 76    EUROPE: ECMO MARKET, BY APPLICATION, 2018–2026 (USD MILLION)    103
11.3.1    GERMANY    103
11.3.1.1    Increasing volume of ECMO procedures to drive market
growth in Germany    103
TABLE 77    GERMANY: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)    103
TABLE 78    GERMANY: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)    103
11.3.2    FRANCE    104
11.3.2.1    Rising healthcare spending to drive market growth in France    104
TABLE 79    FRANCE: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)    104
TABLE 80    FRANCE: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)    104
11.3.3    UK    104
11.3.3.1    Rising adoption of ECMO procedures and increasing prevalence of lifestyle diseases to drive market growth in the UK    104
TABLE 81    UK: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)    105
TABLE 82    UK: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)    105
11.3.4    ITALY    105
11.3.4.1    High burden of CVDs contributing to the growth of the ECMO market in Italy    105
TABLE 83    ITALY: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)    106
TABLE 84    ITALY: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)    106
11.3.5    SPAIN    106
11.3.5.1    High adoption of advanced technologies to drive market
growth in Spain    106
TABLE 85    SPAIN: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)    107
TABLE 86    SPAIN: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)    107
11.4    REST OF EUROPE    107
TABLE 87    REST OF EUROPE: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)    107
TABLE 88    REST OF EUROPE: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION)    108
11.5    ASIA PACIFIC    108
FIGURE 25    ASIA PACIFIC: ECMO MARKET SNAPSHOT    108
TABLE 89    ASIA PACIFIC: ECMO MARKET, BY COUNTRY, 2018–2026 (USD MILLION)    109
TABLE 90    ASIA PACIFIC: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)    109
TABLE 91    ASIA PACIFIC: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION)    109
TABLE 92    ASIA PACIFIC: ECMO MARKET, BY COMPONENT, 2018–2026 (USD MILLION)    110
TABLE 93    ASIA PACIFIC: ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION)    110
TABLE 94    ASIA PACIFIC: ECMO MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)    110
TABLE 95    ASIA PACIFIC: ECMO MARKET, BY APPLICATION, 2018–2026 (USD MILLION)    111
11.5.1    JAPAN    111
11.5.1.1    Favorable healthcare infrastructure in Japan to drive market growth    111
TABLE 96    JAPAN: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)    111
TABLE 97    JAPAN: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)    112
11.5.2    CHINA    112
11.5.2.1    Rising geriatric population and increasing prevalence of
CVD to drive market growth in China    112
TABLE 98    CHINA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)    113
TABLE 99    CHINA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)    113
11.5.3    INDIA    113
11.5.3.1    Growing applications and rising adoption of ECMO to drive market growth in India    113
TABLE 100    INDIA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)    113
TABLE 101    INDIA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)    114
11.5.4    AUSTRALIA    114
11.5.4.1    Technological advancements to drive market growth in Australia    114
TABLE 102    AUSTRALIA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)    114
TABLE 103    AUSTRALIA: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION)    114
11.5.5    SOUTH KOREA    115
11.5.5.1    Increasing incidence of cardiac disorders to drive market growth in South Korea    115
TABLE 104    SOUTH KOREA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)    115
TABLE 105    SOUTH KOREA: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION)    115
11.5.6    REST OF APAC    115
TABLE 106    REST OF APAC: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)    116
TABLE 107    REST OF APAC: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION)    116
11.6    LATIN AMERICA    116
TABLE 108    LATIN AMERICA: ECMO MARKET, BY COUNTRY, 2018–2026 (USD MILLION)    116
TABLE 109    LATIN AMERICA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)    117
TABLE 110    LATIN AMERICA: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION)    117
TABLE 111    LATIN AMERICA: ECMO MARKET, BY COMPONENT,
2018–2026 (USD MILLION)    117
TABLE 112    LATIN AMERICA: ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION)    118
TABLE 113    LATIN AMERICA: ECMO MARKET, BY PATIENT TYPE,
2018–2026 (USD MILLION)    118
TABLE 114    LATIN AMERICA: ECMO MARKET, BY APPLICATION,
2018–2026 (USD MILLION)    118
11.6.1    BRAZIL    119
11.6.1.1    Rising adoption of ECMO as a bridge to heart and lung transplantation to drive market growth in Brazil    119
TABLE 115    BRAZIL: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)    119
TABLE 116    BRAZIL: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)    119
11.6.2    MEXICO    120
11.6.2.1    High burden of CVDs in the country to drive market growth in Mexico    120
TABLE 117    MEXICO: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)    120
TABLE 118    MEXICO: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)    120
11.6.3    REST OF LATIN AMERICA    121
TABLE 119    REST OF LATIN AMERICA: ECMO MARKET, BY PRODUCT,
2018–2026 (USD MILLION)    121
TABLE 120    REST OF LATIN AMERICA: ECMO MACHINES MARKET, BY TYPE,
 2018–2026 (USD MILLION)    121
11.6.4    MIDDLE EAST & AFRICA    121
11.6.4.1    Increasing prevalence of target diseases to drive market growth in the Middle East & Africa    121
TABLE 121    MIDDLE EAST & AFRICA: ECMO MARKET, BY PRODUCT,
2018–2026 (USD MILLION)    122
TABLE 122    MIDDLE EAST & AFRICA: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION)    122
TABLE 123    MIDDLE EAST & AFRICA: ECMO MARKET, BY COMPONENT,
2018–2026 (USD MILLION)    122
TABLE 124    MIDDLE EAST & AFRICA: ECMO MARKET, BY MODALITY,
2018–2026 (USD MILLION)    123
TABLE 125    MIDDLE EAST & AFRICA: ECMO MARKET, BY PATIENT TYPE,
2018–2026 (USD MILLION)    123
TABLE 126    MIDDLE EAST & AFRICA: ECMO MARKET, BY APPLICATION,
2018–2026 (USD MILLION)    123
12    COMPETITIVE LANDSCAPE    124
12.1    INTRODUCTION    124
FIGURE 26    KEY DEVELOPMENTS BY LEADING PLAYERS IN THE ECMO MARKET,
2018–2021    124
12.2    REVENUE SHARE ANALYSIS    125
FIGURE 27    REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE ECMO MARKET    125
12.3    MARKET SHARE ANALYSIS    126
FIGURE 28    ECMO MARKET SHARE, BY KEY PLAYER, 2020    126
TABLE 127    ECMO MARKET: DEGREE OF COMPETITION    126
12.4    COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2020)    127
12.4.1    TERMINOLOGY/NOMENCLATURE    127
12.4.1.1    Stars    127
12.4.1.2    Emerging leaders    127
12.4.1.3    Pervasive players    128
12.4.1.4    Participants    128
FIGURE 29    ECMO MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020    128
12.5    COMPETITIVE LEADERSHIP MAPPING: START-UP/SME EVALUATION QUADRANT (2020)    129
12.5.1    PROGRESSIVE COMPANIES    129
12.5.2    RESPONSIVE COMPANIES    129
12.5.3    DYNAMIC COMPANIES    129
12.5.4    STARTING BLOCKS    129
FIGURE 30    ECMO MARKET: COMPETITIVE LEADERSHIP MAPPING FOR
SMES/START-UPS, 2020    130
12.6    COMPETITIVE BENCHMARKING    131
TABLE 128    PRODUCT FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ECMO MARKET    131
TABLE 129    APPLICATION FOOTPRINT ANALYSIS OF THE TOP PLAYERS
IN THE ECMO MARKET    132
TABLE 130    COMPANY FOOTPRINT ANALYSIS IN THE ECMO MARKET    133
12.7    COMPETITIVE SCENARIO (2018–2021)    134
12.7.1    NEW PRODUCT LAUNCHES & APPROVALS    134
13    COMPANY PROFILES    135
13.1    KEY PLAYERS    135
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1.1    FRESENIUS MEDICAL CARE AG & CO. KGAA    135
TABLE 131    FRESENIUS MEDICAL CARE AG & CO. KGAA: BUSINESS OVERVIEW    135
FIGURE 31    FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY SNAPSHOT    136
TABLE 132    FRESENIUS MEDICAL CARE AG & CO. KGAA: PRODUCT OFFERINGS    136
TABLE 133    FRESENIUS MEDICAL CARE AG & CO. KGAA: PRODUCT LAUNCHES    137
13.1.2    GETINGE GROUP    138
TABLE 134    GETINGE GROUP: BUSINESS OVERVIEW    138
FIGURE 32    GETINGE GROUP: COMPANY SNAPSHOT    139
TABLE 135    GETINGE GROUP: PRODUCT OFFERINGS    140
13.1.3    MEDTRONIC PLC    141
TABLE 136    MEDTRONIC PLC: BUSINESS OVERVIEW    141
FIGURE 33    MEDTRONIC PLC: COMPANY SNAPSHOT    142
TABLE 137    MEDTRONIC PLC: PRODUCT OFFERINGS    142
13.1.4    MICROPORT    144
TABLE 138    MICROPORT: BUSINESS OVERVIEW    144
FIGURE 34    MICROPORT: COMPANY SNAPSHOT    145
TABLE 139    MICROPORT: PRODUCT OFFERINGS    145
13.1.5    TERUMO CARDIOVASCULAR SYSTEMS CORPORATION    146
FIGURE 35    TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: COMPANY SNAPSHOT    146
TABLE 140    TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: BUSINESS OVERVIEW    147
TABLE 141    TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: PRODUCT OFFERINGS    147
13.1.6    NIPRO CORPORATION    148
TABLE 142    NIPRO CORPORATION: BUSINESS OVERVIEW    148
FIGURE 36    NIPRO CORPORATION: COMPANY SNAPSHOT    149
TABLE 143    NIPRO CORPORATION: PRODUCT OFFERINGS    149
13.1.7    LIVANOVA PLC    150
TABLE 144    LIVANOVA PLC.: BUSINESS OVERVIEW    150
FIGURE 37    LIVANOVA PLC.: COMPANY SNAPSHOT    151
TABLE 145    LIVANOVA PLC: PRODUCT OFFERINGS    151
13.1.8    EUROSETS S.R.L.    152
TABLE 146    EUROSETS S.R.L.: BUSINESS OVERVIEW    152
TABLE 147    EUROSETS S.R.L.: PRODUCT OFFERINGS    152
13.1.9    ORIGEN BIOMEDICAL, INC.    153
TABLE 148    ORIGEN BIOMEDICAL, INC.: BUSINESS OVERVIEW    153
TABLE 149    ORIGEN BIOMEDICAL, INC.: PRODUCT OFFERINGS    153
13.1.10    CYTOSORBENTS CORPORATION    154
TABLE 150    CYTOSORBENTS CORPORATION: BUSINESS OVERVIEW    154
TABLE 151    CYTOSORBENTS CORPORATION: PRODUCT OFFERINGS    154
13.1.11    ABIOMED    155
TABLE 152    ABIOMED: BUSINESS OVERVIEW    155
TABLE 153    ABIOMED: PRODUCT OFFERINGS    155
13.1.12    BRAILE BIOMÉDICA    156
TABLE 154    BRAILE BIOMÉDICA: BUSINESS OVERVIEW    156
TABLE 155    BRAILE BIOMÉDICA: PRODUCT OFFERINGS    156
13.1.13    SPECTRUM MEDICAL    157
TABLE 156    SPECTRUM MEDICAL: BUSINESS OVERVIEW    157
TABLE 157    SPECTRUM MEDICAL: PRODUCT OFFERINGS    157
13.1.14    HAEMONETICS    158
TABLE 158    HAEMONETICS: BUSINESS OVERVIEW    158
TABLE 159    HAEMONETICS: PRODUCT OFFERINGS    158
13.1.15    XENIOS AG    159
TABLE 160    XENIOS AG: BUSINESS OVERVIEW    159
TABLE 161    XENIOS AG: PRODUCT OFFERINGS    159
TABLE 162    XENIOS AG: PRODUCT LAUNCHES    160
13.1.16    KANEKA CORPORATION    161
TABLE 163    KANEKA CORPORATION: BUSINESS OVERVIEW    161
TABLE 164    KANEKA CORPORATION: PRODUCT OFFERINGS    161
13.1.17    SB-KAWASUMI LABORATORIES, INC.    162
TABLE 165    SB-KAWASUMI LABORATORIES, INC.: BUSINESS OVERVIEW    162
TABLE 166    SB-KAWASUMI LABORATORIES, INC.: PRODUCT OFFERINGS    162
13.1.18    WEIGAO GROUP    163
TABLE 167    WEIGAO GROUP: BUSINESS OVERVIEW    163
TABLE 168    WEIGAO GROUP: PRODUCT OFFERINGS    163
13.1.19    ZHENGYUAN TECHNOLOGY    164
TABLE 169    ZHENGYUAN TECHNOLOGY: BUSINESS OVERVIEW    164
TABLE 170    ZHENGYUAN TECHNOLOGY: PRODUCT OFFERINGS    164
13.1.20    BREETHE, INC.    165
TABLE 171    BREETHE, INC.: BUSINESS OVERVIEW    165
TABLE 172    BREETHE, INC.: PRODUCT OFFERINGS    165
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14    APPENDIX    166
14.1    DISCUSSION GUIDE    166
14.2    KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL    170
14.3    AVAILABLE CUSTOMIZATIONS    172
14.4    RELATED REPORTS    172
14.5    AUTHOR DETAILS    174"